Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness

Journal of the American Society of Hypertension

Volumn 8, Issue 2, 2014, Pages 74-82

  Koumaras, Charalambos ^a   Tziomalos, Konstantinos ^a   Stavrinou, Eirini ^a   Katsiki, Niki ^a   Athyros, Vasilios G ^a   Mikhailidis, Dimitri P ^b   Karagiannis, Asterios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antihypertensive treatment; augmentation index; central blood pressure; pulse wave velocity

Indexed keywords

ANTIHYPERTENSIVE TREATMENT; AUGMENTATION INDEX; CENTRAL BLOOD PRESSURE; PULSE WAVE VELOCITY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AMIDES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DRUG MONITORING; FEMALE; FUMARATES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE; PULSE WAVE ANALYSIS; RENIN-ANGIOTENSIN SYSTEM; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84894103242     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2013.09.001     Document Type: Article

References (32)

1. G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, and M. Böhm et al. 2013 ESH/ESCGuidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 31 2013 1281 1357
2. S. Laurent, J. Cockcroft, L. Van Bortel, P. Boutouyrie, C. Giannattasio, and D. Hayoz et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications EurHeart J 27 2006 2588 2605
3. N. Katsiki, C. Koumaras, V.G. Athyros, and A. Karagiannis Thinking beyond traditional cardiovascular risk factors: The role of arterial stiffness in targeting residual risk Angiology 63 2012 9 11
4. S. Laurent, P. Boutouyrie, R. Asmar, I. Gautier, B. Laloux, and L. Guize et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients Hypertension 37 2001 1236 1241
5. M.J. Roman, R.B. Devereux, J.R. Kizer, E.T. Lee, J.M. Galloway, and T. Ali et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study Hypertension 50 2007 197 203
6. C. Koumaras, N. Katsiki, V.G. Athyros, and A. Karagiannis Metabolic syndrome and arterial stiffness: the past, the present and the future J Cardiovasc Med 2013 In press
7. E. Agabiti-Rosei, G. Mancia, M.F. O'Rourke, M.J. Roman, M.E. Safar, and H. Smulyan et al. Central blood pressure measurements and antihypertensive therapy: a consensus document Hypertension 50 2007 154 160
8. L. Ghiadoni, R.M. Bruno, F. Stea, A. Virdis, and S. Taddei Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension Curr Hypertens Rep 11 2009 190 196
9. K.T. Ong, S. Delerme, B. Pannier, M.E. Safar, A. Benetos, S. Laurent investigators Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients J Hypertens 29 2011 1034 1042
10. A.D. Protogerou, G.S. Stergiou, C. Vlachopoulos, J. Blacher, and A. Achimastos The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplification Curr Pharm Des 15 2009 272 289
11. C. Koumaras, M. Tzimou, E. Stavrinou, T. Griva, T.D. Gossios, and N. Katsiki et al. Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics Am J Cardiovasc Drugs 12 2012 143 156
12. A. Mahmud, and J. Feely Arterial stiffness and the renin-angiotensin- aldosterone system J Renin Angiotensin Aldosterone Syst 5 2004 102 108
13. P. Jankowski, M.E. Safar, and A. Benetos Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system Curr Pharm Des 15 2009 571 584
14. A.D. Protogerou, T.G. Papaioannou, J.P. Lekakis, J. Blacher, and M.E. Safar The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (patho)-physiology, rationale and perspective on pulse pressure amplification Curr Pharm Des 15 2009 267 271
15. J.Q. Guo, H.Y. Wang, and N.L. Sun Effect of aliskiren on arterial stiffness, compared with ramipril in patients with mild to moderate essential hypertension Chin Med J (Engl) 126 2013 1242 1246
16. A. Virdis, L. Ghiadoni, A.A. Qasem, G. Lorenzini, E. Duranti, and G. Cartoni et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients Eur Heart J 33 2012 1530 1538
17. T. Kanaoka, K. Tamura, M. Ohsawa, H. Wakui, A. Maeda, and T. Dejima et al. Effects of aliskiren-based therapy on ambulatory blood pressure profile, central hemodynamics, and arterial stiffness in nondiabetic mild to moderate hypertensive patients J Clin Hypertens (Greenwich) 14 2012 522 529
18. D.Z. Cherney, J.W. Scholey, S. Jiang, R. Har, V. Lai, and E.B. Sochett et al. The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes Diabetes Care 35 2012 2324 2330
19. G.M. London, R.G. Asmar, M.F. O'Rourke, M.E. Safar REASON Project Investigators Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol J Am Coll Cardiol 43 2004 92 99
20. B. Williams, P.S. Lacy, S.M. Thom, K. Cruickshank, A. Stanton, D. Collier CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 2006 1213 1225
21. A. Karagiannis, V.G. Athyros, A. Papageorgiou, K. Tziomalos, and M. Elisaf Should atenolol still be recommended as first-line therapy for primary hypertension? Hellenic J Cardiol 47 2006 298 307
22. A. Karagiannis, D.P. Mikhailidis, A.I. Kakafika, K. Tziomalos, and V.G. Athyros Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome? Curr Pharm Des 13 2007 229 239
23. J. Polónia, L. Barbosa, J.A. Silva, and S. Bertoquini Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers Blood Press Monit 15 2010 235 239
24. A. Mahmud, and J. Feely Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection Am J Hypertens 21 2008 663 667
25. Z. Dhakam, Yasmin, C.M. McEniery, T. Burton, M.J. Brown, and I.B. Wilkinson A comparison of atenolol and nebivolol in isolated systolic hypertension J Hypertens 26 2008 351 356
26. E. Agabiti-Rosei, E. Porteri, and D. Rizzoni Arterial stiffness, hypertension, and rational use of nebivolol Vasc Health Risk Manag 5 2009 353 360
27. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein-cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
28. T. Kaiser, T. Heise, L. Nosek, U. Eckers, and P.T. Sawicki Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients J Hypertens 24 2006 1397 1403
29. J. Topouchian, A.M. Brisac, B. Pannier, E. Vicaut, M. Safar, and R. Asmar Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study J Hum Hypertens 12 1998 181 187
30. K.A. Aznaouridis, K.S. Stamatelopoulos, E.N. Karatzis, A.D. Protogerou, C.M. Papamichael, and J.P. Lekakis Acute effects of renin-angiotensin system blockade on arterial function in hypertensive patients J Hum Hypertens 21 2007 654 663
31. G.M. London, B. Pannier, E. Vicaut, A.P. Guérin, S.J. Marchais, and M.E. Safar et al. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition J Hypertens 14 1996 1139 1146
32. G. Spanos, R. Kalaitzidis, D. Karasavvidou, K. Pappas, and K.C. Siamopoulos Efficacy of aliskiren and valsartan in hypertensive patients with albuminuria: a randomized parallel-group study J Renin Angiotensin Aldosterone Syst 2012 Nov 10.1177/1470320312465219 [Epub ahead of print]